Homeβ€ΊSearchβ€ΊRSC Medicinal Chemistry

RSC Medicinal Chemistry

Royal Society of Chemistry Β· United Kingdom Β· Est. 2006

ISSN2632-8682eISSN2632-8682
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJR
90
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (2 more)+12
Total90
Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
Publication speed: not measurable
publisher doesn’t disclose per-article submission dates β€” we never estimate
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.756
H-Indexi
50
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
0.954
Total Worksi
1,722
Total Citationsi
15,038
2yr Mean Citednessi
3.28
Open Impact Factor alternative

Aims & Scope

Research articles published in this journal must show a breakthrough or significant advance on previously published work, or bring new thinking or results that will have a strong impact in their field. Examples of areas within the journal's scope are: Design, synthesis and biological evaluation of novel chemical entities or biotherapeutic modalities. To be suitable for publication these must exhibit significant potential as new pharmacological agents, tools, probes or potential drugs. Modifications of known chemical entities or biotherapeutic modalities that result in a significantly greater understanding of their structure-activity relationships, an improvement of their properties or provide other information of significant value, for example, the identification of a new target or mode of action for a known agent. Routine modifications with minimal or no improvement are not suitable for  RSC Medicinal Chemistry . Novel methodologies and technologies in the broader chemical and biological sciences (for example, enabling synthetic chemistry, chemical biology, -omics sciences, nanoscience) with application to drug discovery, target identification or elucidation of the mechanism of action. Biological studies should present sufficient innovation with respect to the chemistry. Computational studies are welcome where they significantly advance medicinal chemistry knowledge. Studies that use established computational methods should include an original prediction and be accompanied by new experimental data which validates the prediction made. Studies that report novel computational methodology must demonstrate its use in medicinal chemistry through comparison with experimental data. Computational research that does not clearly relate the results obtained to experimental data or that has no demonstrated utility (or where the utility is unlikely to advance the field significantly) is not suitable for RSC Medicinal Chemistry. Docking studies presented without experimental data are not suitable for publication in the journal. Studies that examine the effect of the molecular structure of a compound on pharmacokinetic behaviour and pharmacodynamics. Studies that present new insights into drug design based on analysis of existing experimental datasets or new theoretical approaches if supported by experimental evidence. Studies presenting new drug delivery systems with novel chemical agents are welcomed, in particular those that involve chemical modification of the delivery system of conjugation with novel delivery vectors. Those that focus solely on formulations of known drugs are not suitable for publication in RSC Medicinal Chemistry. Note that studies where new or existing compounds are tested as pharmacological agents will only be considered if they are carried out in the presence of clear positive and negative controls. Studies of this type should include a clearly defined and hypothesis-driven compound design rationale. Potential antimicrobial agents should be tested for cytotoxicity and activity against non-related pathogens. To help editors and referees assess the significance of each submitted manuscript we ask all authors on submission to provide a brief statement of significance. This should contain one sentence to summarise the most important finding(s) in the manuscript and a second sentence to say why this is a significant advance in the field. This significance statement should focus specifically on the importance of the piece of research being submitted, rather than the importance of the field. Readership Researchers in academia and industry studying medicinal chemistry, pharmacology, and topics in the wider chemical, biological and materials sciences with application to biological problems.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published2006
FrequencyMonthly
StatusActive (last: 2026)
Total Publications1,722
Publisher OrgRoyal Society of Chemistry
Visit Journal Website

Submission Info

Peer Reviewβ€”
Review Timeβ€”
Acceptance Rateβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes

Think.Check.Submit Compliance

6/12 Β· 50%
βœ…
Do you know the journal / publisher?
Royal Society of Chemistry
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
2632-8682 / 2632-8682
βœ…
Indexed in a trusted database?
WoS, Scopus, PubMed
❌
Peer review process documented?
N/A
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
❌
Plagiarism detection in place?
N/A
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
14
320
2019
184
3.5k
2020
203
4.3k
2021
181
2.2k
2022
244
2.5k
2023
369
2.7k
2024
427
1.1k
2025
169
34
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Organic ChemistryQ1
BiochemistryQ2
Drug DiscoveryQ2
Molecular MedicineQ2
Pharmaceutical ScienceQ2
PharmacologyQ2

Subject Classification

Web of Science Categories

Biochemistry & Molecular BiologyChemistry, Medicinal

Scopus Categories

Molecular MedicinePharmacologyDrug DiscoveryBiochemistryPharmaceutical ScienceOrganic Chemistry

Research Topics (OpenAlex)

Synthesis and biological activityClick Chemistry and ApplicationsComputational Drug Discovery MethodsCancer therapeutics and mechanismsSynthesis and Biological EvaluationProtein Degradation and InhibitorsChemical Synthesis and AnalysisAntibiotic Resistance in BacteriaPeptidase Inhibition and AnalysisBioactive Compounds and Antitumor Agents

Frequently asked questions about RSC Medicinal Chemistry

Is RSC Medicinal Chemistry a predatory journal?

PubScope has no integrity flags on record for RSC Medicinal Chemistry: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 90/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of RSC Medicinal Chemistry?

RSC Medicinal Chemistry is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 3.28.

Is RSC Medicinal Chemistry indexed in Scopus and Web of Science?

RSC Medicinal Chemistry is indexed in Web of Science, Scopus.

What is the aims and scope of RSC Medicinal Chemistry?

Research articles published in this journal must show a breakthrough or significant advance on previously published work, or bring new thinking or results that will have a strong impact in their field. Examples of areas within the journal's scope are: Design, synthesis and biological evaluation of novel chemical entities or biotherapeutic modalities. To be suitable for publication these must exhibit significant potential as new pharmacological agents, tools, probes or potential drugs. Modifications of known chemical entities or biotherapeutic modalities that result in a significantly greater u

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref